Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin.

Standard

Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin. / Rades, Dirk; Kuhn, Hildegard; Schultze, Juergen; Homann, Nils; Brandenburg, Bernd; Schulte, Rainer; Krüll, Andreas; Schild, Steven E; Dunst, Juergen.

In: INT J RADIAT ONCOL, Vol. 70, No. 4, 4, 2008, p. 1087-1093.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Rades, D, Kuhn, H, Schultze, J, Homann, N, Brandenburg, B, Schulte, R, Krüll, A, Schild, SE & Dunst, J 2008, 'Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin.', INT J RADIAT ONCOL, vol. 70, no. 4, 4, pp. 1087-1093. <http://www.ncbi.nlm.nih.gov/pubmed/17892921?dopt=Citation>

APA

Rades, D., Kuhn, H., Schultze, J., Homann, N., Brandenburg, B., Schulte, R., Krüll, A., Schild, S. E., & Dunst, J. (2008). Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin. INT J RADIAT ONCOL, 70(4), 1087-1093. [4]. http://www.ncbi.nlm.nih.gov/pubmed/17892921?dopt=Citation

Vancouver

Rades D, Kuhn H, Schultze J, Homann N, Brandenburg B, Schulte R et al. Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin. INT J RADIAT ONCOL. 2008;70(4):1087-1093. 4.

Bibtex

@article{f667db811e4b4937982da9d548187ed1,
title = "Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin.",
abstract = "PURPOSE: To investigate potential prognostic factors, including hemoglobin levels before and during radiotherapy, for associations with survival and local control in patients with unirradiated locally recurrent rectal cancer. PATIENTS AND METHODS: Ten potential prognostic factors were investigated in 94 patients receiving radiotherapy for recurrent rectal cancer: age (or=69 years), gender, Eastern Cooperative Oncology Group performance status (0-1 vs. 2-3), American Joint Committee on Cancer (AJCC) stage (50 Gy), and hemoglobin levels before (or=12 g/dL) and during (majority of levels: or=12 g/dL) radiotherapy. Multivariate analyses were performed, including hemoglobin levels, either before or during radiotherapy (not both) because these are confounding variables. RESULTS: Improved survival was associated with better performance status (por=12 g/dL both before (p=0.031) and during (por=12 g/dL before (p",
author = "Dirk Rades and Hildegard Kuhn and Juergen Schultze and Nils Homann and Bernd Brandenburg and Rainer Schulte and Andreas Kr{\"u}ll and Schild, {Steven E} and Juergen Dunst",
year = "2008",
language = "Deutsch",
volume = "70",
pages = "1087--1093",
journal = "INT J RADIAT ONCOL",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin.

AU - Rades, Dirk

AU - Kuhn, Hildegard

AU - Schultze, Juergen

AU - Homann, Nils

AU - Brandenburg, Bernd

AU - Schulte, Rainer

AU - Krüll, Andreas

AU - Schild, Steven E

AU - Dunst, Juergen

PY - 2008

Y1 - 2008

N2 - PURPOSE: To investigate potential prognostic factors, including hemoglobin levels before and during radiotherapy, for associations with survival and local control in patients with unirradiated locally recurrent rectal cancer. PATIENTS AND METHODS: Ten potential prognostic factors were investigated in 94 patients receiving radiotherapy for recurrent rectal cancer: age (or=69 years), gender, Eastern Cooperative Oncology Group performance status (0-1 vs. 2-3), American Joint Committee on Cancer (AJCC) stage (50 Gy), and hemoglobin levels before (or=12 g/dL) and during (majority of levels: or=12 g/dL) radiotherapy. Multivariate analyses were performed, including hemoglobin levels, either before or during radiotherapy (not both) because these are confounding variables. RESULTS: Improved survival was associated with better performance status (por=12 g/dL both before (p=0.031) and during (por=12 g/dL before (p

AB - PURPOSE: To investigate potential prognostic factors, including hemoglobin levels before and during radiotherapy, for associations with survival and local control in patients with unirradiated locally recurrent rectal cancer. PATIENTS AND METHODS: Ten potential prognostic factors were investigated in 94 patients receiving radiotherapy for recurrent rectal cancer: age (or=69 years), gender, Eastern Cooperative Oncology Group performance status (0-1 vs. 2-3), American Joint Committee on Cancer (AJCC) stage (50 Gy), and hemoglobin levels before (or=12 g/dL) and during (majority of levels: or=12 g/dL) radiotherapy. Multivariate analyses were performed, including hemoglobin levels, either before or during radiotherapy (not both) because these are confounding variables. RESULTS: Improved survival was associated with better performance status (por=12 g/dL both before (p=0.031) and during (por=12 g/dL before (p

M3 - SCORING: Zeitschriftenaufsatz

VL - 70

SP - 1087

EP - 1093

JO - INT J RADIAT ONCOL

JF - INT J RADIAT ONCOL

SN - 0360-3016

IS - 4

M1 - 4

ER -